The effect of Tamsulosin in facilitation of gravel expulsion after ureteroscopic lithotripsy

The effect of Tamsulosin, an alpha-1 receptor antagonist in ureteroscopic lithotripsy (URSL) success rate

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201212261981N2

Enrollment

102

Registered

2013-03-13

Start date

2008-06-01

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Distal ureter stones. Urolithiasis

Interventions

Intervention 1: In control group one 0.4 mg placebo capsule daily ( like tamsulosin) orally for 2 weeks. Intervention 2: In study group one 0.4 mg tamsulosin capsule daily orally for 2 weeks.

Treatment - Drugs

In control group one 0.4 mg placebo capsule daily ( like tamsulosin) orally for 2 weeks

In study group one 0.4 mg tamsulosin capsule daily orally for 2 weeks

Eligibility

Sex/Gender

All

Age

17 Years to 36 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria:lower ureter stone ; single stone ; radio opaque stone ; 5-10 mm diameter stone Exclusion criteria: urinary tract infections;high-grade hydronephrosis; diabetes;hypersensitivity to a -blockers; ureteral stricture;pregnant women

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Success rate of ureteroscopic lithotripsy( stone clearance). Timepoint: 2 weeks. Method of measurement: imaging methods.	—

Secondary

Measure	Time frame
Complications. Timepoint: from start of procedure until 2 weeks. Method of measurement: by questinerie and imaging.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Ali Asghar Ketabchi

Kerman University of Medical Science

dr.ketabchi@gmail.com+98 34 1211 4348

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026